All News

Akeega, the first dual action tablet with a PARP inhibitor and abiraterone acetate, was approved for the treatment of patients with suspected or confirmed BRCA-positive metastatic castration-resistant prostate cancer.

A phase 1 clinical trial just launched and will test the novel agent, CLN-978, for relapsed/refractory B-cell non-Hodgkin lymphoma.

There are two different types of lung cancer — small cell and non-small cell lung cancer — that behave differently and therefore require different treatments, an expert explained.

Don’t waste your cancer.

From Jill Martin revealing an updated about her cancer to Casey DeSantis announcing breast cancer diagnosis, this is what’s happening in the oncology space this week.

Patients with metastatic clear cell renal cell carcinoma who received corticosteroids during Opdivo treatment did not experience a negative impact on survival.

There are multiple types of skin cancer and treatments to treat the disease, too, explained an expert.

The ongoing chemotherapy shortage is preventing some clinical research from happening, resulting in both short- and long-term implications for cancer care.

The importance of cascade genetic testing has led me to advocate through my artwork.

Bill C. Potts, author and five-time cancer survivor, lends his experience and tips about cancer to others in his book, “Up for the Fight.”

The FDA granted an accelerated approval for Talvey to treat patients with relapsed/refractory multiple myeloma.

Artificial intelligence platforms such as ChatGPT are offering patients a more personal and conversational way to research their cancer, an expert said.

This regular approval provides Gavreto as a treatment option for patients with metastatic RET fusion-positive non-small cell lung cancer.

“I flow, I change constantly, I am my grief, I am my joy, I am human, I am divine light, I can submerge when I make the time.” — Shosh Madick.

Patients with myelodysplastic syndrome should seek an expert opinion on their disease to ensure an accurate diagnosis and proper treatment plan.

Researchers have found a new risk biomarker that can detect the early beginnings of graft-versus-host disease in new study.

Patients with head and neck cancer treated with dysphagia-optimized intensity-modulated radiotherapy had improved swallow function compared with those treated with standard intensity-modulated radiotherapy.

In conjunction with Cancer Champions, CURE® recently hosted the “Educated Patient® Webinar: An Overview of Diet and Exercise in Cancer Care."

One of the most common side effects of cancer treatment must be the chills, feeling cold all the time.

Many patients with skin cancer who were treated with immune checkpoint inhibition experienced long-term side effects, although some resolved over time, research showed.

I was devastated when I had to stop working due to my cancer diagnosis. However, I eventually found a new line of work that I'm grateful for.

Tecentriq, compared with chemotherapy, improved survival while maintaining quality-of-life in patients with non-small cell lung cancer considered ineligible for platinum-based chemotherapy.

I’ve heard of many stories of friendships dwindling after someone has been diagnosed with cancer. One thing about it is that I can relate.

An ongoing phase 1 trial is analyzing the use of a novel cancer vaccine plus the immunotherapy agent, Keytruda, for patients with triple-negative breast cancer.

My doctor and I have different communication styles, though it is extremely important that we understand each other.

When my daughter was going through cancer, I realized that connecting with one her peers going through a similar experience was incredibly helpful.

Enjoying things right in front of me.

We took a look back at the most noteworthy and compelling myeloprolifearative neoplasm stories from 2023.

Researchers conducting this trial will compare zipalertinib plus chemotherapy with chemotherapy alone in patients with previously untreated, locally advanced or metastatic non-small cell lung cancer with the EGFR exon 20 insertion mutation.